title: [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
authors.forename: J
authors.initials: J
authors.lastname: Gallego Gómez
authors.forename: J F
authors.initials: JF
authors.lastname: Jiménez Cruz
authors.forename: E
authors.initials: E
authors.lastname: Martínez Agulló
authors.forename: J A
authors.initials: JA
authors.lastname: Mompó Sanchís
authors.forename: B
authors.initials: B
authors.lastname: Llopis Mínguez
authors.forename: F
authors.initials: F
authors.lastname: Boronat Tormo
mesh_terms: D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009530:Nicergoline / Q000627:therapeutic use*; D010643:Phenoxybenzamine / Q000627:therapeutic use; D001750:Urinary Bladder, Neurogenic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D014563:Urodynamics; D014718:Vesico-Ureteral Reflux / Q000209:etiology / Q000517:prevention & control
chemical_list: D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D010643:Phenoxybenzamine; D009530:Nicergoline
vernacular_title: Posibilidades terapéuticas de la nicergolina en la disfunción vesical neurógena.